307 filings
ARS
2023 FY
APRE
Aprea Therapeutics Inc
25 Apr 24
Annual report to shareholders
7:30am
DEFA14A
APRE
Aprea Therapeutics Inc
25 Apr 24
Additional proxy soliciting materials
7:15am
DEF 14A
APRE
Aprea Therapeutics Inc
Definitive proxy
25 Apr 24
7:00am
8-K
APRE
Aprea Therapeutics Inc
10 Apr 24
IND for APR-1051 has been cleared; details on planned Phase 1 first in human trial (ACESOT-1051) presented
4:15pm
S-3
APRE
Aprea Therapeutics Inc
Shelf registration
3 Apr 24
4:06pm
4
APRE
Aprea Therapeutics Inc
28 Mar 24
Aprea Therapeutics / John P. Hamill ownership change
5:59pm
4
Oren Gilad
28 Mar 24
Aprea Therapeutics / Oren Gilad ownership change
5:57pm
8-K
APRE
Aprea Therapeutics Inc
26 Mar 24
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
8:15am
10-K
2023 FY
APRE
Aprea Therapeutics Inc
Annual report
26 Mar 24
7:45am
4
APRE
Aprea Therapeutics Inc
14 Mar 24
Aprea Therapeutics / John P. Hamill ownership change
8:54pm
4
Seizinger Bernd R.
14 Mar 24
Aprea Therapeutics / Bernd R. Seizinger ownership change
8:53pm
4
APRE
Aprea Therapeutics Inc
14 Mar 24
Aprea Therapeutics / JOHN B HENNEMAN III ownership change
8:52pm
4
Oren Gilad
14 Mar 24
Aprea Therapeutics / Oren Gilad ownership change
8:51pm
8-K
APRE
Aprea Therapeutics Inc
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
SC 13G
APRE
Aprea Therapeutics Inc
14 Feb 24
Aprea Therapeutics / Sio Capital Management ownership change
8:00am
424B3
APRE
Aprea Therapeutics Inc
9 Feb 24
Prospectus supplement
12:00am
SC 13G/A
Hirschman Orin
7 Feb 24
Aprea Therapeutics / HIRSCHMAN ORIN ownership change
6:55pm
8-K
APRE
Aprea Therapeutics Inc
6 Feb 24
Other Events
5:01pm
EFFECT
APRE
Aprea Therapeutics Inc
5 Feb 24
Notice of effectiveness
12:15am
424B3
APRE
Aprea Therapeutics Inc
5 Feb 24
Prospectus supplement
12:00am